Cargando…

Pediatric outpatient visits and antibiotic use attributable to higher valency pneumococcal conjugate vaccine serotypes

IMPORTANCE: Streptococcus pneumoniae is a known etiology of acute respiratory infections (ARIs), which account for large proportions of outpatient visits and antibiotic use in children. In 2023, 15- and 20-valent pneumococcal conjugate vaccines (PCV15, PCV20) were recommended for routine use in infa...

Descripción completa

Detalles Bibliográficos
Autores principales:	King, Laura M, Andrejko, Kristin L, Kabbani, Sarah, Tartof, Sara Y, Hicks, Lauri A, Cohen, Adam L, Kobayashi, Miwako, Lewnard, Joseph A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473805/ https://www.ncbi.nlm.nih.gov/pubmed/37662372 http://dx.doi.org/10.1101/2023.08.24.23294570

Ejemplares similares

Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis
por: Andrejko, Kristin, et al.
Publicado: (2021)

Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
por: Owusu-Edusei, Kwame, et al.
Publicado: (2022)

Estimating the Cost-Effectiveness of Switching to Higher-Valency Pediatric Pneumococcal Conjugate Vaccines in the United Kingdom
por: Wilson, Michele, et al.
Publicado: (2023)

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines
por: Lee, Hyunju, et al.
Publicado: (2014)

Correction to: Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
por: Owusu-Edusei, Kwame, et al.
Publicado: (2022)

2728. Proportion of Invasive Pneumococcal Disease Potentially Covered by Current and Next-Generation of Higher-Valency Pneumococcal Conjugate Vaccines in Canada, 2010–2016
por: Dion, Stephane B, et al.
Publicado: (2019)

Optimal Serotype Compositions for Pneumococcal Conjugate Vaccination under Serotype Replacement
por: Nurhonen, Markku, et al.
Publicado: (2014)

Impact of Pneumococcal Conjugate Vaccine on Vaccine Serotype–Specific Pneumonia
por: Klugman, Keith P, et al.
Publicado: (2020)

Characterization of pneumococcal serotype 7F in vaccine conjugation
por: Deng, James Z, et al.
Publicado: (2023)

Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine
por: Lee, Joon Kee, et al.
Publicado: (2017)

Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine
por: Lee, Joon Kee, et al.
Publicado: (2017)

1173. Risk of Pneumococcal Disease and Rate of Pneumococcal Vaccination Among Medicare Beneficiaries Aged 65 Years and Older Residing in Long-Term Care Facilities — United States, September 1, 2014 – December 31, 2019
por: Kobyashi, Miwako, et al.
Publicado: (2023)

Effectiveness of Pneumococcal Conjugate Vaccination Against Virus-Associated Lower Respiratory Tract Infection Among Adults: A Case-Control Study
por: Lewnard, Joseph A, et al.
Publicado: (2022)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
por: Fernández-Delgado, Lucía, et al.
Publicado: (2021)

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine
por: Patel, Sweta M., et al.
Publicado: (2022)

Pneumococcal Conjugate Vaccine Impact on Serotype 3: A Review of Surveillance Data
por: Sings, Heather L., et al.
Publicado: (2021)

2707. Non 13-Valent Pneumococcal Conjugate Vaccine Serotypes Predominate as Causes of Pneumococcal Otitis Media in Children
por: Hulten, Kristina G, et al.
Publicado: (2019)

Identifying Higher-Volume Antibiotic Outpatient Prescribers Using Publicly Available Medicare Part D Data — United States, 2019
por: Gouin, Katryna A., et al.
Publicado: (2022)

Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines
por: Benfield, Thomas, et al.
Publicado: (2013)

Periodic cycles of pneumococcal serotypes carried by children before and after 7-valent pneumococcal conjugate vaccine
por: Paulo, Ana Cristina, et al.
Publicado: (2017)

Changes in the Pneumococcal Vaccine Serotypes in Adult Noninvasive Pneumonia after the Introduction of Pneumococcal Conjugate Vaccination for Children
por: Takeda, Hiroaki, et al.
Publicado: (2019)

Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan
por: Nisar, Muhammad Imran, et al.
Publicado: (2022)

Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media
por: Izurieta, Patricia, et al.
Publicado: (2022)

1718. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: an indirect cohort study
por: Andrejko, Kristin, et al.
Publicado: (2023)

576. Burden of Pneumococcal Disease Due to Serotypes Covered by the 13-Valent and New Higher-Valent Pneumococcal Conjugate Vaccines in All Children and Children at Risk in the United States
por: Huang, Liping, et al.
Publicado: (2022)

Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011
por: Richter, Sandra S., et al.
Publicado: (2013)

Antibody enhanced HPLC for serotype-specific quantitation of polysaccharides in pneumococcal conjugate vaccine
por: Deng, James Z., et al.
Publicado: (2023)

Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany
por: van der Linden, Mark, et al.
Publicado: (2015)

Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in Bangladesh
por: Baqui, Abdullah H., et al.
Publicado: (2020)

Prevention of Coronavirus Disease 2019 Among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions Between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract
por: Lewnard, Joseph A, et al.
Publicado: (2021)

Outpatient antibiotic prescribing during the COVID-19 pandemic–United States, January 2019–October 2021
por: Bizune, Destani, et al.
Publicado: (2022)

Decline in Vaccine-Type Streptococcus pneumoniae Serotypes Following Pneumococcal Conjugate Vaccine Introduction in Madagascar
por: Raboba, Julia L, et al.
Publicado: (2021)

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C
por: Shi, Yaru, et al.
Publicado: (2023)

Outpatient Antibiotic Prescribing Among Older Adults in the United States, 2011 to 2014
por: Kabbani, Sarah, et al.
Publicado: (2017)

Model estimates of the burden of outpatient visits attributable to influenza in the United States
por: Matias, Gonçalo, et al.
Publicado: (2016)

Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency
por: Løchen, Alessandra, et al.
Publicado: (2020)

Rapid replacement by non-vaccine pneumococcal serotypes may mitigate the impact of the pneumococcal conjugate vaccine on nasopharyngeal bacterial ecology
por: Kwambana-Adams, Brenda, et al.
Publicado: (2017)

Pneumococcal Conjugate Vaccine Safety in Elderly Adults
por: Tseng, Hung Fu, et al.
Publicado: (2018)

Higher valent Pneumococcal Conjugate Vaccines: is it a roller coaster?
por: Oligbu, Godwin
Publicado: (2020)

Persistence of Nasopharyngeal Pneumococcal Vaccine Serotypes and Increase of Nonvaccine Serotypes Among Vaccinated Infants and Their Mothers 5 Years After Introduction of Pneumococcal Conjugate Vaccine 13 in The Gambia
por: Usuf, Effua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_69rsqo3mnvu7lmhi1pbtvqac7k